Price $259.75 |
Market Cap
69.39B
|
Sector Health Care |
Div. Growth
4.60%
|
|
P/E
74.3
|
P/B
3.28
|
P/S
4.76
|
Dividend %
1.10%
|
|
P/CF
-
|
P/FCF
67.6
|
Op. Cash Flow
2.69M
|
FCF
3.8
|
|
Op. Margin
9.20%
|
Net Margin
4.20%
|
ROE
3.20%
|
ROI
4.80%
|
|
ROA
1.20%
|
EPS Growth
-33.10%
|
Current Ratio
5.6
|
Debt/Equity
144.20%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Assertio Therapeutics Inc (ASRT) | $5.96 | - | - | 416.4M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $5.62 | - | - | 96.4M | Strong Buy |
| Procyon Corp (PCYN) | $0.23 | - | - | 2M | Strong Buy |
| American Renal Associates Hold (ARA) | $20.46 | - | - | 720.1M | Strong Buy |
| Civitas Solutions Inc (CIVI) | $14.30 | - | - | 574.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
